Development of a new method to screen anticancer drug and to assess drug efficacy using three dimensional (3D) images of tumor spheroids measured by optical coherence tomography (OCT)

Tamio Mizukami; Hirotaka Taguchi; Yuma Wada; Yuki Togo; Makoto Hasegawa; Miho Hosoi; Mie Tsuchida; Ryuzo Sasaki; Hiroki Fujimoto; Kenji Ueyama; Masayoshi Kobayashi

4:45 PM - 6:45 PM

[2P0933] Development of a new method to screen anticancer drug and to assess drug efficacy using three dimensional (3D) images of tumor spheroids measured by optical coherence tomography (OCT)

〇Tamio Mizukami¹, Hirotaka Taguchi¹, Yuma Wada¹, Yuki Togo¹, Makoto Hasegawa¹, Miho Hosoi², Mie Tsuchida², Ryuzo Sasaki², Hiroki Fujimoto³, Kenji Ueyama³, Masayoshi Kobayashi³ (1.Dept. of BioSci., Nagahama Inst. Bio-Sci. & Tech., 2.Frontier Pharma, 3.SCREEN Holdings)

Optical Coherence Tomography, OCT

This archive has moved to the member page of The Molecular Biology Society of Japan and The Japanese Biochemical Society.
Members of the either society can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

BMB2015 Biochemistry and Molecular Biology

[2P0933] Development of a new method to screen anticancer drug and to assess drug efficacy using three dimensional (3D) images of tumor spheroids measured by optical coherence tomography (OCT)

Password